» Articles » PMID: 2033257

Cathepsin B Cleavage of Ii from Class II MHC Alpha- and Beta-chains

Overview
Journal J Immunol
Date 1991 Jun 1
PMID 2033257
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Class II MHC-associated invariant chain (Ii) might regulate binding of digested peptides to the Ag binding site (desetope) of class II MHC proteins by directly or allosterically blocking that site until cleavage and release of Ii from MHC alpha- and beta-chains at the time of peptide charging. We examined the cleavage and release of Ii from class II MHC alpha/beta Ii trimers by cathepsin B, which has been shown by others to colocalize with class II MHC molecules in intracellular compartments and to generate antigenic peptide fragments. Cathepsin B at pH 5.0 cleaved and released Ii from class II MHC alpha- and beta-chains. Cathepsin B digested Ii from alpha- and beta-chains in a dose-dependent fashion, yielding 23-, 21-, and 10-kDa fragments. Blockage of cathepsin B activity with leupeptin restored the 2D(nonequilibrium pH gradient gel electrophoresis/SDS) PAGE patterns of Ii and sialic acid-derivatized forms of Ii seen without the protease. The fragmentation pattern of cathepsin D treatment was different from that of cathepsin B, yielding 25-kDa intermediates.

Citing Articles

Cathepsin B Dipeptidyl Carboxypeptidase and Endopeptidase Activities Demonstrated across a Broad pH Range.

Yoon M, Hook V, ODonoghue A Biochemistry. 2022; 61(17):1904-1914.

PMID: 35981509 PMC: 9454093. DOI: 10.1021/acs.biochem.2c00358.


Hepatic Stellate Cells and Hepatocytes as Liver Antigen-Presenting Cells during Infection.

Arriola Benitez P, Pesce Viglietti A, Elizalde M, Giambartolomei G, Quarleri J, Delpino M Pathogens. 2020; 9(7).

PMID: 32629846 PMC: 7399813. DOI: 10.3390/pathogens9070527.


Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.

Meng Z, Klinngam W, Edman M, Hamm-Alvarez S PLoS One. 2017; 12(9):e0184781.

PMID: 28902875 PMC: 5597228. DOI: 10.1371/journal.pone.0184781.


Immune evasion strategies used by Helicobacter pylori.

Lina T, Alzahrani S, Gonzalez J, Pinchuk I, Beswick E, Reyes V World J Gastroenterol. 2014; 20(36):12753-66.

PMID: 25278676 PMC: 4177461. DOI: 10.3748/wjg.v20.i36.12753.


CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

Beswick E, Reyes V World J Gastroenterol. 2009; 15(23):2855-61.

PMID: 19533806 PMC: 2699002. DOI: 10.3748/wjg.15.2855.